Examkin

Soru

Zorluk: OrtaDiagnostic and Screening Test Performance

A 45-year-old woman presents to her primary care physician with fatigue, intermittent joint pain, and a faint facial rash. The physician suspects systemic lupus erythematosus (SLE) and orders an antinuclear antibody (ANA) test. The prevalence of SLE in patients presenting with these non-specific symptoms in a general primary care setting is approximately 2%. In a specialized rheumatology clinic where the assay was originally validated, the prevalence of SLE among tested patients is 30%. The ANA test has a reported sensitivity of 95% and a specificity of 80%. When comparing the performance of the ANA test in the general primary care setting to its performance in the rheumatology clinic, which of the following best describes the test characteristics in the primary care setting?

  1. Lower positive predictive value and higher negative predictive valueCevap
  2. B
    Higher positive predictive value and lower negative predictive value
  3. C
    Lower positive predictive value and lower sensitivity
  4. D
    Higher negative predictive value and higher specificity
  5. E
    Equivalent positive and negative predictive values

Cevap

Lower positive predictive value and higher negative predictive value
The correct answer identifies that lowering the prevalence of a disease within a tested population decreases the positive predictive value (PPV) and increases the negative predictive value (NPV) of a diagnostic test. Because the disease is much rarer in the primary care setting (2%) compared to the rheumatology clinic (30%), a positive ANA test is far more likely to be a false positive (yielding a lower PPV), and a negative test is more likely to be a true negative (yielding a higher NPV). The intrinsic characteristics of the test—sensitivity and specificity—remain theoretically constant regardless of the population being tested.

Adım Adım Çözüm

1
Identify the change in disease prevalence between the two settings.
The prevalence decreases from 30% in the rheumatology clinic to 2% in the primary care setting.
Prevalence (pre-test probability) is the key variable that affects a diagnostic test's predictive values.
2
Determine the effect of decreased prevalence on positive predictive value (PPV).
A lower prevalence means there are fewer true positives and relatively more false positives in the population, which decreases the PPV.
PPV equals True Positives divided by (True Positives + False Positives). As disease rarity increases, false positives comprise a much larger fraction of all positive test results.
3
Determine the effect of decreased prevalence on negative predictive value (NPV).
A lower prevalence means there are fewer false negatives and relatively more true negatives, which increases the NPV.
NPV equals True Negatives divided by (True Negatives + False Negatives). As disease rarity increases, true negatives comprise a larger fraction of all negative test results.
4
Evaluate the effect on sensitivity and specificity.
Sensitivity and specificity remain unchanged.
These are intrinsic statistical properties of the diagnostic test itself and do not depend on the prevalence of the disease in the population being tested.

Anahtar Kavram

Effect of disease prevalence on predictive values
Bu soruyu puanla

Konular

Diagnostic and Screening Test Performance

Bu konudan daha fazla soru